Recursion Pharmaceuticals

Take a glimpse at the industry's largest biological images dataset which we released June 28th to be used as part of the NeurIPS 2019 competition track. Generated entirely in-house at Recursion, for the development of new ML algorithms for drug discovery. We have raised over $200M to apply machine learning to one of the most unique datasets in existence - over 12 billion images of cells under a huge number of biological and chemical perturbations, generated in our own labs - in order to find treatments for hundreds of diseases. Our long term mission is to decode biology to radically improve lives - we want to understand biology so well that we can fix most things that go wrong in our bodies.